It is an open secret that in the spring and summer of 2019 the company quietly hired investigators to try to figure out who inside of Alkermes was posting negative information on Cafepharma. Based on what they thought they found out, a number of those people were let go in the big October 2019 layoff.
Maybe Sarissa should review the cost of hiring these investigators to see if that was a prudent use of company resources. It would also be interesting for Sarissa to look into what Federal and State privacy laws the company may have violated in conducting cyber surveillance on what employees do on their own time and with there own personal computers.
So...how has the company done since they think they rooted out those disloyal people? Well, the high-water mark for the stock in 2019 was $37.16, while the high-water mark in 2022 was $30.53, and our current stock price is $26.67. The "truth tellers" on Cafepharma are not to blame for that. That rests entirely with the continued mismanagement of our C Suite, under the singularly inept leadership of Richard Popps.
Maybe Sarissa should review the cost of hiring these investigators to see if that was a prudent use of company resources. It would also be interesting for Sarissa to look into what Federal and State privacy laws the company may have violated in conducting cyber surveillance on what employees do on their own time and with there own personal computers.
So...how has the company done since they think they rooted out those disloyal people? Well, the high-water mark for the stock in 2019 was $37.16, while the high-water mark in 2022 was $30.53, and our current stock price is $26.67. The "truth tellers" on Cafepharma are not to blame for that. That rests entirely with the continued mismanagement of our C Suite, under the singularly inept leadership of Richard Popps.